68
|
248
|
3fe4A |
Crystal structure of human carbonic anhydrase vi |
78
|
256
|
3efiA |
Carbonic anhydrase activators: kinetic and x-ray crystallographic study for the interaction of d- and l-tryptophan with the mammalian isoforms i-xiv |
77
|
256
|
3eftA |
Crystal structure of the complex between carbonic anhydrase ii and a spin-labeled sulfonamide incorporating tempo moiety |
77
|
258
|
3dvcA |
X-ray crystal structure of mutant n62t of human carbonic anhydrase ii |
75
|
258
|
3dv7A |
Role of hydrophilic residues in proton transfer during catalysis by human carbonic anhydrase ii (n62a) |
73
|
258
|
3dvbA |
X-ray crystal structure of mutant n62v human carbonic anhydrase ii |
76
|
258
|
3dvdA |
X-ray crystal structure of mutant n62d of human carbonic anhydrase ii |
77
|
257
|
3dc9A |
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
77
|
257
|
3dccA |
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
77
|
256
|
3dd8A |
Carbonic anhydrase inhibitors. interaction of the antitumor sulfamate emd-486019 with twelve mammalian isoforms: kinetic and x-ray crystallographic studies |
76
|
257
|
3dcsA |
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
75
|
258
|
3dd0A |
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
75
|
257
|
3d8wA |
Use of a carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
76
|
257
|
3d9zA |
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
74
|
257
|
3dazA |
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
76
|
257
|
3d93A |
Apo human carbonic anhydrase ii bound with substrate carbon dioxide |
76
|
258
|
3czvA |
Crystal structure of the human carbonic anhydrase xiii in complex with acetazolamide |
81
|
263
|
3d0nA |
Crystal structure of human carbonic anhydrase xiii |
76
|
257
|
3dc3A |
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
71
|
257
|
3cyuA |
Human carbonic anhydrase ii complexed with cryptophane biosensor and xenon |
74
|
257
|
3d92A |
Human carbonic anhydrase ii bound with substrate carbon dioxide |
75
|
262
|
3da2A |
X-ray structure of human carbonic anhydrase 13 in complex with inhibitor |
78
|
258
|
3c7pA |
Crystal structure of human carbonic anhydrase ii in complex with stx237 |
76
|
258
|
3cajA |
Crystal structure of the human carbonic anhydrase ii in complex with ethoxzolamide |
78
|
256
|
3ca2A |
Crystallographic studies of inhibitor binding sites in human carbonic anhydrase ii. a pentacoordinated binding of the scn-ion to the zinc at high p*h |
71
|
256
|
3bl1A |
Carbonic anhydrase inhibitors. sulfonamide diuretics revisited old leads for new applications |
76
|
257
|
3bl0A |
Carbonic anhydrase inhibitors. interaction of 2-n,n-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with twelve mammalian isoforms: kinetic and x-ray crystallographic studies |
74
|
258
|
3betA |
Crystal structure of the human carbonic anhydrase ii in complex with stx 641 at 1.85 angstroms resolution |
91
|
357
|
3b1bA |
The unique structure of wild type carbonic anhydrase alpha-ca1 from chlamydomonas reinhardtii |
80
|
256
|
3b4fA |
Carbonic anhydrase inhibitors. interaction of 2-(hydrazinocarbonyl)-3-phenyl-1h-indole-5-sulfonamide with twelve mammalian isoforms: kinetic and x-ray crystallographic studies |
62
|
258
|
2zncA |
Murine carbonic anhydrase iv |
73
|
257
|
2x7uA |
Structures of human carbonic anhydrase ii inhibitor complexes reveal a second binding site for steroidal and non-steroidal inhibitors. |
75
|
257
|
2x7sA |
Structures of human carbonic anhydrase ii inhibitor complexes reveal a second binding site for steroidal and non-steroidal inhibitors. |
75
|
257
|
2x7tA |
Structures of human carbonic anhydrase ii inhibitor complexes reveal a second binding site for steroidal and non-steroidal inhibitors. |
77
|
258
|
2wehA |
Thermodynamic optimisation of carbonic anhydrase fragment inhibitors |
74
|
257
|
2wd3A |
Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template |
73
|
258
|
2wd2A |
A chimeric microtubule disruptor with efficacy on a taxane resistant cell line |
75
|
258
|
2wejA |
Thermodynamic optimisation of carbonic anhydrase fragment inhibitors |
76
|
257
|
2weoA |
Thermodynamic optimisation of carbonic anhydrase fragment inhibitors |
75
|
258
|
2wegA |
Thermodynamic optimisation of carbonic anhydrase fragment inhibitors |
77
|
258
|
2vvaX |
Human carbonic anhydrase in complex with co2 |
78
|
268
|
2w2jA |
Crystal structure of the human carbonic anhydrase related protein viii |
76
|
258
|
2vvbX |
Human carbonic anhydrase ii in complex with bicarbonate |
76
|
257
|
2qoaA |
Crystal structure of the complex of hcaii with an indane-sulfonamide inhibitor |
76
|
258
|
2qp6A |
The crystal structure of the complex of hcaii with a bioreductive antitumor derivative |
76
|
259
|
2qo8A |
Crystal structure of the complex of hcaii with an indane-sulfonamide inhibitor |
77
|
256
|
2q1bA |
Carbonic anhydrase ii in complex with saccharin |
75
|
256
|
2q38A |
Carbonic anhydrase ii in complex with saccharin at 1.95 angstrom |
73
|
257
|
2powA |
The crystal structure of the human carbonic anhydrase ii in complex with 4-amino-6-trifluoromethyl-benzene-1,3-disulfonamide |
77
|
257
|
2q1qA |
Carbonic anhydrase inhibitors. interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: kinetic and x-ray crystallographic studies |